Curious about how a SynCardia Total Artificial Heart is made? This overview gives you a sneak peek into our manufacturing process.
The SynCardia Total Artificial Heart is a life-saving treatment option for patients diagnosed with end-stage heart failure affecting both sides of the heart.
For children and adolescents diagnosed with end-stage congenital heart failure, there’s hope.
Thanks to the amazing team at Texas Children’s Hospital and the SynCardia Total Artificial Heart, 17-year-old Jordan was able to overcome end-stage congenital heart disease and receive a heart transplant. Read his amazing story here.
The SynCardia temporary Total Artificial Heart (TAH) allows for complete resection of the ventricles, including in patients who have cardiac tumors with ventricular involvement, providing long-term support until heart transplantation is possible.
Six years after her first heart transplant, Lexi was admitted to the hospital with severe cardiac allograft vasculopathy. Her doctors decided to implant the SynCardia Total Artificial Heart to bridge her to a second transplant. Read her full story here.